Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UBE2C |
| Upstream (Parents) |
|---|
| (<<) ATIC → UBE2C |
| (<<) BZW2 → UBE2C |
| (<<) CCNB2 → UBE2C |
| (<<) CYP4F2 → UBE2C |
| (<<) FZD4 → UBE2C |
| (<<) MYC → UBE2C |
| (<<) YWHAB → UBE2C |
| Downstream (Children) |
|---|
| UBE2C → ADORA2B (>>) |
| UBE2C → ASNS (>>) |
| UBE2C → ATP10B (>>) |
| UBE2C → ATP2C2 (>>) |
| UBE2C → B3GNT3 (>>) |
| UBE2C → CCNE1 (>>) |
| UBE2C → CDK4 (>>) |
| UBE2C → E2F1 (>>) |
| UBE2C → EIF6 (>>) |
| UBE2C → ELF3 (>>) |
| UBE2C → EMG1 (>>) |
| UBE2C → EREG (>>) |
| UBE2C → EWSR1 (>>) |
| UBE2C → HDAC2 (>>) |
| UBE2C → HMGA2 (>>) |
| UBE2C → HSPA14 (>>) |
| UBE2C → KLF11 (>>) |
| UBE2C → KRT1 (>>) |
| UBE2C → MAPK13 (>>) |
| UBE2C → MAPKAPK5 (>>) |
| UBE2C → MEX3D (>>) |
| UBE2C → NXT1 (>>) |
| UBE2C → ODC1 (>>) |
| UBE2C → ORC6L (>>) |
| UBE2C → PLK1 (>>) |
| UBE2C → PPP1R3D (>>) |
| UBE2C → RPIA (>>) |
| UBE2C → SFN (>>) |
| UBE2C → SLC7A5 (>>) |
| UBE2C → SLMO2 (>>) |
| UBE2C → SPAG5 (>>) |
